Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

Here are four things to know. 1. Levetiracetam is intended to treat partial onset seizures related to epilepsy. 2. The tablets are a generic equivalent to UCB’s brand name drug Keppra XR. 3. Sales of ...

Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It blocks the ...

Amyloid plaques are misfolded proteins aggregates between neurons, Alzheimer's disease illustration. [Artur Plawgo/Getty Images] Scientists have long known Alzheimer’s disease (AD) involves the build ...

This leaflet answers some common questions about LEVETIRACETAM VIATRIS tablets. It does not contain all the available information. It does not take the place of talking to your physician or pharmacist ...

January 25, 2012 — The US Food and Drug Administration (FDA) has given the go-ahead for the use of levetiracetam (Keppra, UCB Pharmaceuticals) as adjunctive treatment for partial-onset seizures in ...

Scientists examined engineered mouse models, human neurons and brains of Down syndrome patients, who are at high risk of developing an aggressive form of Alzheimer’s Decades-old, FDA-approved drug ...

Dec. 9, 2003 (Boston) -- An unknown number of physicians prescribe levetiracetam (Keppra) off-label as a single-drug therapy for epilepsy, but researchers in California and Minnesota have found cause ...

MUMBAI, May 23 (Reuters) - Drug maker Alembic Ltd. said on Wednesday it had signed a deal to out-license its novel drug delivery platform to Belgium's UCB for the latter's anti-epileptic drug Keppra ...